Shree Rajeshwaranand Paper Mills has approved a revised list of allottees for its proposed preferential issue of 1.2 crore equity shares. Valued at Rs 12 crore, this move is part of the company's long-standing restructuring plan initiated in July 2025. The company will now seek in-principle approval from the BSE to move forward with the share issuance, which represents a significant shift in its post-allotment capital structure.
Shree Rajeshwaranand Paper Mills Revises Preferential Share Allotment Plan
1.2 crore equity shares set for issuance valued at Rs 12 crore.
Proposed issue represents approximately 94.81% of the company's post-allotment equity capital.
Reader Takeaway: The revised allottee list signals movement in a restructuring plan, but existing shareholders face significant equity dilution.
What just happened
The Board of Directors at Shree Rajeshwaranand Paper Mills met on October 8, 2026, to approve a revised list of proposed allottees for its preferential share issuance. This decision formally supersedes previous filings submitted to the BSE on August 21 and September 19, 2026. The company is now authorized to seek in-principle listing approval from the BSE for these 1.2 crore shares, issued at a face value of Rs 10 each.
Why this matters
This preferential issue is a critical component of a broader capital restructuring proposal that has been in progress since July 2025. By issuing shares to new allottees, the company is significantly altering its ownership structure. The scale of this issuance, representing nearly 95% of the post-allotment capital, is a major event for current investors, as it implies substantial dilution of existing holdings.
The backstory
The company initially proposed this equity infusion during a board meeting on July 10, 2025. Over the subsequent 15 months, the management has been navigating the regulatory requirements to finalize the list of allottees. This update serves as the latest procedural milestone to bring the restructuring plan closer to final execution under SEBI regulations.
Risks to watch
Investors should closely track the progress of the in-principle approval application with the BSE. Delays in receiving these approvals or further revisions to the allottee list could extend the timeline of the restructuring process. The high degree of dilution associated with this issuance also remains a primary consideration for the existing equity base.
What to track next
The next phase involves the successful receipt of in-principle approval from the BSE. Following this, market participants should watch for formal announcements regarding the final allotment and the impact of the newly issued shares on the company's balance sheet and operational liquidity.
